Josh Schimmer analyst CANTOR FITZGERALD

Currently out of the existing stock ratings of Josh Schimmer, 87 are a BUY (86.14%), 13 are a HOLD (12.87%), 1 are a SELL (0.99%).

Josh Schimmer

Work Performance Price Targets & Ratings Chart

Analyst Josh Schimmer works at CANTOR FITZGERALD with a stock forecast success ratio of 52.1% fulfilled within 248.21 days on average.

Josh Schimmer’s has documented 545 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 14-May-2024.

Wall Street Analyst Josh Schimmer

Analyst best performing recommendations are on SPRO (SPERO THERAPEUTICS).
The best stock recommendation documented was for SPRO (SPERO THERAPEUTICS) at 5/4/2022. The price target of $2 was fulfilled within 2 days with a profit of $0.25 (14.29%) receiving and performance score of 71.43.

Average potential price target upside

ALXN Alexion Pharmaceuticals BLU BELLUS Health . DICE Dice Molecules Holdings LLC FDMT 4D Molecular Therapeutics  HRTX Heron Therapeuti INSM Insmed IONS Ionis Pharmaceuticals MDGL Madrigal Pharmaceuticals REGN Regeneron Pharmaceuticals RGNX Regenxbio SPRO Spero Therapeutics VTYX Ventyx Biosciences CABA Cabaletta Bio ICVX Icosavax INBX Inhibrx  ADMS Adamas Pharmaceuticals GOSS Gossamer Bio RNA Avidity Biosciences  ZYME Zymeworks . Common Stock AKRO Akero Therapeutics BBIO BridgeBio Pharma CRNX Crinetics Pharmaceuticals ERAS Erasca INCY yte KDNY Chinook Therapeutics KRYS Krystal Biotech ASND Ascendis Pharma AS PMVP Pmv Pharmaceuticals  LBPH Longboard Pharmaceuticals MIRM Mirum Pharmaceuticals XENE Xenon Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

3 years 21 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

3 years 23 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 3 months 22 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 3 months 22 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 4 months 19 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Josh Schimmer is most bullish on?

Potential upside of $50.59 has been obtained for ASND (ASCENDIS PHARMA AS)

Which stock is Josh Schimmer is most reserved on?

Potential downside of $15.45 has been obtained for MIRM (MIRUM PHARMACEUTICALS)

What Year was the first public recommendation made by Josh Schimmer?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?